Re: Disease X
|
4
|
Resverlogix Corp.
|
Jan 22, 2024 01:45PM
|
Re: Does anyone know the record date for incentive stock options?
|
4
|
Resverlogix Corp.
|
Sep 29, 2016 08:24PM
|
Re: Does anyone know the record date for incentive stock options?
|
2
|
Resverlogix Corp.
|
Sep 29, 2016 10:30PM
|
Re: Does anyone know the record date for incentive stock options?
|
2
|
Resverlogix Corp.
|
Sep 29, 2016 10:36PM
|
Re: Don Bio at Wallmine
|
5
|
Resverlogix Corp.
|
Oct 07, 2020 05:59AM
|
Re: Don On 630 CHED's Afternoon Show
|
5
|
Resverlogix Corp.
|
Jan 20, 2022 05:35PM
|
Re: Don On 630 CHED's Afternoon Show
|
4
|
Resverlogix Corp.
|
Jan 20, 2022 09:37AM
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
6
|
Resverlogix Corp.
|
Aug 17, 2022 10:56AM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
3
|
Resverlogix Corp.
|
Mar 25, 2022 07:17PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
5
|
Resverlogix Corp.
|
Mar 25, 2022 11:08PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
2
|
Resverlogix Corp.
|
Mar 26, 2022 09:22AM
|
Re: Duo of Star Factories
|
2
|
Resverlogix Corp.
|
Jun 23, 2016 03:24PM
|
Re: Entresto Trial (Novartis)
|
4
|
Resverlogix Corp.
|
Jun 24, 2020 10:30AM
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
3
|
Resverlogix Corp.
|
Jan 17, 2016 08:23PM
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
4
|
Resverlogix Corp.
|
Jan 18, 2016 06:12PM
|
Re: Equity Based Compensation & Expiring Incentive Stock Options
|
|
Resverlogix Corp.
|
Apr 25, 2017 11:54AM
|
Re: Equity Based Compensation & Expiring Incentive Stock Options
|
4
|
Resverlogix Corp.
|
Apr 24, 2017 03:35PM
|
Re: Eversana ValuationCaseStudy
|
8
|
Resverlogix Corp.
|
Jan 04, 2022 02:29PM
|
Re: Eversana ValuationCaseStudy
|
2
|
Resverlogix Corp.
|
Jan 04, 2022 02:34PM
|
Re: Exercise of rights / Red (-) Green (+)
|
4
|
Resverlogix Corp.
|
Oct 09, 2016 11:53AM
|